| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |